Hardy nodded to the issues he faces in BioMarins statement announcing his hiring identifying the opportunity that lies ahead in unlocking the full value of Voxzogo and Roctavian Genentech tapped Hardy as CEO in 2019 and before that he held a number of roles there and at Roche Genetechs parent company including leading patient access services and serving as head of global product strategy